Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
Glavni autori: | , , , , |
---|---|
Daljnji autori: | |
Format: | Conference item |
Jezik: | English |
Izdano: |
Oxford University Press
2017
|